A detailed history of High Vista Strategies LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 52,107 shares of KROS stock, worth $870,707. This represents 1.18% of its overall portfolio holdings.

Number of Shares
52,107
Previous 39,208 32.9%
Holding current value
$870,707
Previous $1.79 Million 68.9%
% of portfolio
1.18%
Previous 0.72%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.68 - $58.07 $537,630 - $749,044
12,899 Added 32.9%
52,107 $3.03 Million
Q1 2024

May 15, 2024

BUY
$41.26 - $70.48 $1.62 Million - $2.76 Million
39,208 New
39,208 $2.6 Million
Q4 2022

Feb 14, 2023

BUY
$39.45 - $51.77 $734,401 - $963,750
18,616 New
18,616 $893,000
Q2 2022

Aug 15, 2022

BUY
$26.03 - $67.04 $15,175 - $39,084
583 Added 3.63%
16,623 $459,000
Q1 2022

May 16, 2022

BUY
$42.12 - $59.36 $675,604 - $952,134
16,040 New
16,040 $872,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $430M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.